Literature DB >> 24608455

Relative quantitative expression of hypoxia-inducible factor 1α messenger ribonucleic acid in recurrent craniopharyngiomas.

Hao Liu, Zhiyong Liu, Jin Li, Qiang Li, Chao You, Jianguo Xu1.   

Abstract

BACKGROUND: Craniopharyngioma is a benign tumor, but recurrences are common and prognosis is poor. The pathologic mechanism underlying the high recurrence is still unknown. AIMS: We hypothesized that there are hypoxic microenvironments within craniopharyngiomas and hypoxia inducible factor-1 alpha (HIF-1α) and its related genes are largely expressed in recurrent craniopharyngiomas.
MATERIALS AND METHODS: A total of 19 patients with craniopharyngiomas have been identified. The relative quantitative expressions of HIF-1α, vascular endothelial growth factor (VEGF) and carbonic adhydrase 9 (CA9) messenger ribonucleic acid (mRNA) of craniopharyngioma tissues were detected by real time reverse transcription polymerase chain reaction.
RESULTS: HIF-1α and VEGF mRNA was significantly up-regulated in recurrent craniopharyngiomas. Mean expression levels (recurrent craniopharyngiomas compared with non-recurrent craniopharyngiomas, as normalized to expression of β-actin) were 3.09 versus 0.75 (P = 0.001) for HIF-1α, 1.07 versus 0.32 (P = 0.000) for VEGF, 1.21 versus 1.93 (P = 0.503) for CA9. In craniopharyngiomas, the expression of VEGF showed a significant correlation with HIF-1α (r = 0.836, P = 0.000).
CONCLUSION: There were hypoxic microenvironments within craniopharyngiomas. Therefore, preventing the tumor cells from adapting to the hypoxic conditions may be an effective way to obviate the relapse of craniopharyngioma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24608455     DOI: 10.4103/0028-3886.128291

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  5 in total

Review 1.  Histopathological and molecular predictors of growth patterns and recurrence in craniopharyngiomas: a systematic review.

Authors:  Josephine R Coury; Brittany N Davis; Christoforos P Koumas; Giovanna S Manzano; Amir R Dehdashti
Journal:  Neurosurg Rev       Date:  2018-04-17       Impact factor: 3.042

2.  Treatment of Cystic Craniopharyngiomas: An Update.

Authors:  Federico Bianchi; Alberto Benato; Luca Massimi
Journal:  Adv Tech Stand Neurosurg       Date:  2022

3.  Integrative analyses identify HIF-1α as a potential protective role with immune cell infiltration in adamantinomatous craniopharyngioma.

Authors:  Qiang Gao; Jing Luo; Jingjing Pan; Longxiao Zhang; Dengpan Song; Mingchu Zhang; Dingkang Xu; Fuyou Guo
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786

4.  Downregulation of HIF-1α inhibits the proliferation and invasion of non-small cell lung cancer NCI-H157 cells.

Authors:  Jialin Qian; Hao Bai; Zhiqiang Gao; Y U Dong; Jun Pei; Meili Ma; Baohui Han
Journal:  Oncol Lett       Date:  2016-01-26       Impact factor: 2.967

5.  Effect of Hypoxia on DDR1 Expression in Pituitary Adenomas.

Authors:  Shouchun Li; Zhiwen Zhang; Jinghui Xue; Xiaoming Guo; Shuli Liang; Aijun Liu
Journal:  Med Sci Monit       Date:  2015-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.